EUVIMEDEUVIMED entdecken
Crossref

Comparison of Therapies to Reduce Total Cholesterol And Glucose Levels in Type II Diabetics

Ghazal Raza, Muhammad Sajid Abbas Jaffri, Shabih Zehra

Medical Forum Monthly · 04.09.2023 · 34 (8)

DOI: 10.60110/medforum.340803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Forum Monthly, online erschienen am 04.09.2023. Verfasst von Ghazal Raza und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the effectiveness of high dose pitavastatin and intermediate dose pitavastatin combined with ezetimibe in lowering total cholesterol (TC) in diabetic patients on metformin. Secondary endpoint is to compare glycosylated hemoglobin (HbA1c) levels after therapy. Study Design: Observational / comparative study Place and Duration of Study: This study was conducted at the NMC and PNS Shifa Hospitals from January 2022 to June 2022. Materials and Methods: Patients diagnosed according to international guidelines were included in the study. Consultation was conducted by physicians; glycosylated hemoglobin and lipid tests were performed in pathology labs of the above-mentioned hospitals before and after intervention.

Results

Sample of 50 individuals was divided into two groups of 25 patients. HbA1c and TC levels were assessed before and after 3 months of therapy. TC was significantly higher in group A compared to group B after treatment (U = 172.5, p = 0.006). Mean TC after therapy dropped to 73.7±18 mg/dl, a change of 64.9% in group A and to 60.7±15.6 mg/dl, a 67.83% change in group B. HbA1c was marginally higher in group B compared to group A after therapy (U = 311, p = 0.981).

Conclusion

Metformin-pitavastatin (2 mg)-ezetimibe lowered TC levels significantly in type II diabetics compared to metformin-pitavastatin (4 mg) group. HbA1c dropped considerably in both groups, but the difference was not statistically significant.

Zitieren

APA

Raza, G., Jaffri, M. S. A., & Zehra, S. (2023). Comparison of Therapies to Reduce Total Cholesterol And Glucose Levels in Type II Diabetics. Medical Forum Monthly, 34(8). https://doi.org/10.60110/medforum.340803

Vancouver

Raza G, Jaffri MSA, Zehra S. Comparison of Therapies to Reduce Total Cholesterol And Glucose Levels in Type II Diabetics. Medical Forum Monthly. 2023;34(8). doi:10.60110/medforum.340803

BibTeX
@article{Raza2023,
  author = {Raza, Ghazal and Jaffri, Muhammad Sajid Abbas and Zehra, Shabih},
  title = {Comparison of Therapies to Reduce Total Cholesterol And Glucose Levels in Type II Diabetics},
  journal = {Medical Forum Monthly},
  year = {2023},
  volume = {34},
  number = {8},
  doi = {10.60110/medforum.340803}
}
Kostenlos starten →